Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link Source: Eur Respir J 2009; 33: 1467-1484 Year: 2009
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
The influence of glucose tolerance on plasma oxidative stress markers in obstructive sleep apnea males Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007
Possible relationships between sleep apnea syndrome, blood biochemical parameters and cardiovascular risk Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Plasma antioxidant factors in persons with different stages of obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007
Regional body fat distribution and cardiovascular risk factors in men with obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 343s Year: 2001
Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Obstructive sleep apnea and levels of physical activity and its association with elevated cardiovascular risk in chilean adults Source: International Congress 2018 – Diagnostics including questionnaires Year: 2018
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities Source: Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018 Year: 2018
Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities Source: Eur Respir J 2007; 29: 156-178 Year: 2007